临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00197145 | Infection, Human Immunodeficie... 展开 >>ncy Virus I 收起 << | Phase 3 | Terminated | - | - |
NCT00197145 | - | Terminated | - | - | |
NCT00098306 | HIV Infections | Phase 2 Phase 3 | Completed | - | United States, California ... 展开 >> Pfizer Investigational Site Sacramento, California, United States, 95825 Pfizer Investigational Site San Francisco, California, United States, 94115 Pfizer Investigational Site San Francisco, California, United States, 94118 Pfizer Investigational Site San Francisco, California, United States, 94121 United States, Colorado Pfizer Investigational Site Auroa, Colorado, United States, 80045 Pfizer Investigational Site Aurora, Colorado, United States, 80045 United States, District of Columbia Pfizer Investigational Site Washington, District of Columbia, United States, 20036 United States, Florida Pfizer Investigational Site Tampa, Florida, United States, 33602 Pfizer Investigational Site Tampa, Florida, United States, 33614 Pfizer Investigational Site Vero Beach, Florida, United States, 32960 United States, Georgia Pfizer Investigational Site Atlanta, Georgia, United States, 30308 United States, Louisiana Pfizer Investigational Site New Orleans, Louisiana, United States, 70112 United States, New Mexico Pfizer Investigational Site Santa Fe, New Mexico, United States, 87505 United States, New York Pfizer Investigational Site Bronx, New York, United States, 10467 Pfizer Investigational Site New York, New York, United States, 10003 Pfizer Investigational Site Rochester, New York, United States, 14642 United States, Ohio Pfizer Investigational Site Cincinnati, Ohio, United States, 45267-0405 United States, Oregon Pfizer Investigational Site Portland, Oregon, United States, 97219 United States, Texas Pfizer Investigational Site Austin, Texas, United States, 78705 United States, Virginia Pfizer Investigational Site Annandale, Virginia, United States, 22003 Canada, British Columbia Pfizer Investigational Site Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Quebec Pfizer Investigational Site Montreal, Quebec, Canada, H2L 4P9 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
0.22mL 0.04mL 0.02mL |
1.11mL 0.22mL 0.11mL |
2.23mL 0.45mL 0.22mL |